Bullous acral erythema and concomitant pigmentation on the face and occluded skin.
Ozkaya-Bayazit
E
E
Diz-Küçükkaya
R
R
Akasya
E
E
Büyükbabani
N
N
Oncü
S
S
Pekçelen
Y
Y
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology / Q000473:pathology*; D004890:Erythema / Q000139:chemically induced*; D005260:Female; D006229:Hand Dermatoses / Q000139:chemically induced*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced*
D003561:Cytarabine; D016572:Cyclosporine; D003630:Daunorubicin